Video Experimental Relacionado
Updated: Apr 17, 2026
08:05
Electrophysiological Methods to Assess Peripheral Pain Block in an Anesthetized Rat
Published on: November 21, 2025
304
El GABA bloquea las señales de dolor TRPV1 patológicas pero no agudas
Christina Hanack1, Mirko Moroni2, Wanessa C Lima3
1Department of Pharmacology, University of Heidelberg, Im Neuenheimer Feld 366, 69120 Heidelberg, Germany; Max Delbrück Center for Molecular Medicine, Robert-Rössle-Strasse 10, 13125 Berlin, Germany.
Cell
|February 14, 2015
Resumen
La subunidad del receptor GABAB1 inhibe la sensibilización del receptor de capsaicina TRPV1, que está involucrado en el dolor patológico. Este descubrimiento sugiere un nuevo objetivo terapéutico para el manejo del dolor mediante el aprovechamiento de este mecanismo de retroalimentación natural.
Área de la Ciencia:
- La neurociencia es la neurociencia.
- Investigación del dolor Investigación del dolor.
- Biología Molecular Biología Molecular
Sus antecedentes:
- La sensibilización del receptor de capsaicina TRPV1 es crucial para iniciar el dolor patológico.
- Las condiciones inflamatorias activan cascadas de señalización que mejoran la actividad de TRPV1, contribuyendo a la escalada del dolor.
Objetivo del estudio:
- Para identificar los mecanismos que contrarrestan la escalada perjudicial de la actividad TRPV1.
- Para investigar el papel de la subunidad del receptor GABAB1 en la regulación de la sensibilización TRPV1.
Principales métodos:
- Se empleó un enfoque genético-proteómico para identificar inhibidores de la sensibilización al TRPV1.
- Investigó la interacción y las vías de señalización entre los receptores GABAB1 y TRPV1.
Principales resultados:
- Identificó la subunidad del receptor GABAB1 como un inhibidor directo de la sensibilización TRPV1 en entornos inflamatorios.
- Se demostró que la liberación endógena de GABA de los terminales nociceptivos sugiere un bucle de retroalimentación autocrino.
- Se demostró que el efecto inhibidor de GABAB1 es independiente de la señalización de la proteína G, dependiendo de la proximidad del receptor al TRPV1.1.
Conclusiones:
- La subunidad del receptor GABAB1 actúa como un freno fisiológico en la sensibilización TRPV1.
- Dirigirse a la interacción GABAB1-TRPV1 ofrece una estrategia potencial para la terapia analgésica con efectos secundarios reducidos en comparación con los bloqueadores de TRPV1.
Videos de Conceptos Relacionados
01:20Pain
2.0K
Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
2.0K
01:25Analgesia and Pain Management
3.2K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.2K
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.8K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.8K
01:44Nociception
35.0K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
35.0K
01:24Local Anesthetics: Differential Sensitivity of Nerve Fibers
1.7K
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
1.7K
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
5.0K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
5.0K